MYC and neoplasm: Some oncogene/tumor suppressor products (Myc, p53, or cell cycle inhibitors and kinases) already fulfill the criteria of being important nodes; however, understanding how they influence different pathways is limited by lack of (a) how they participate in different complexes and networks and (b) how their levels/mutation status affects complex composition and function within and between different cell types in tumor tissues.